InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Discover the full record of transactions filed by David Redfern, President, Corporate Development. Director active across 1 company, notably GSK plc. Cumulatively, 1 reports have been logged. History available since 12 May 2026. The latest transaction was filed on 12 May 2026 (Purchase). Regulator: RNS (LSE). All data is accessible without signup.
Declarations1 total
14 shares@ £18.7780.0000% mcap100.0% of flowLondon Stock Exchange (XLON)RNS:9569357-3
Ideal exit: 6 Feb 2027 (T+270)
1 of 1 declaration
About David Redfern
David Redfern is the Chief Executive Officer and Head of Corporate Development at GSK plc. In this role, he oversees the company's growth and expansion initiatives. His experience in the pharmaceutical sector enables him to guide the company towards new opportunities.
